Chemoinformaics analysis of ROSMANOL-9-ETHYL-ETHER
| Molecular Weight | 458.551 | nRot | 5 |
| Heavy Atom Molecular Weight | 424.279 | nRig | 22 |
| Exact Molecular Weight | 458.23 | nRing | 4 |
| Solubility: LogS | -4.601 | nHRing | 1 |
| Solubility: LogP | 4.732 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 67 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 1 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 6 |
| nHA | 7 | APOL | 71.705 |
| nHD | 0 | BPOL | 43.657 |
| QED | 0.465 |
| Synth | 5.165 |
| Natural Product Likeliness | 2.091 |
| NR-PPAR-gamma | 0.145 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.001 |
| HIA | 0.125 |
| CACO-2 | -4.977 |
| MDCK | 0.000014 |
| BBB | 0.963 |
| PPB | 0.911495 |
| VDSS | 0.769 |
| FU | 0.18033 |
| CYP1A2-inh | 0.036 |
| CYP1A2-sub | 0.343 |
| CYP2c19-inh | 0.458 |
| CYP2c19-sub | 0.903 |
| CYP2c9-inh | 0.758 |
| CYP2c9-sub | 0.477 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.135 |
| CYP3a4-inh | 0.416 |
| CYP3a4-sub | 0.703 |
| CL | 2.055 |
| T12 | 0.063 |
| hERG | 0.001 |
| Ames | 0.069 |
| ROA | 0.986 |
| SkinSen | 0.124 |
| Carcinogencity | 0.108 |
| EI | 0.111 |
| Respiratory | 0.493 |
| NR-Aromatase | 0.948 |
| Antiviral | Yes |
| Prediction | 0.875361 |